Obesity leads to enhanced circulating levels of insulin, IGF-I, IGF-II and IGF-binding proteins (IGFBP-3), while reducing levels of the low molecular weight IGF-binding proteins (IGFBP-1, IGFBP-2). This evidence concerns the gene IGF2 and obesity disorder.